- Previous Close
2,108.00 - Open
2,108.00 - Bid 2,124.00 x --
- Ask 2,134.00 x --
- Day's Range
2,094.00 - 2,136.00 - 52 Week Range
1,896.00 - 2,310.00 - Volume
2,226,400 - Avg. Volume
2,426,741 - Market Cap (intraday)
1.721T - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
15.92 - EPS (TTM)
133.44 - Earnings Date Feb 12, 2025 - Feb 17, 2025
- Forward Dividend & Yield 71.00 (3.37%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
2,281.82
Kirin Holdings Company, Limited engages in food and beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, whiskey, spirits, soft drinks, dairy products, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the factories and theme park businesses; management and operation of a chain of Kirin City beer pubs; and manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks; manufacture of Four Roses bourbon; transport logistic services; shared services, such as accounting, human resources, and real estate; Internal information system development; sales of feed; insurance agent; and sales of the supplements; research, development, manufacture, and sale of cosmetics and health foods. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.
www.kirinholdings.co.jp30,183
Full Time Employees
December 31
Fiscal Year Ends
Consumer Defensive
Sector
Beverages—Brewers
Industry
Recent News: 2503.T
View MoreCompare To: 2503.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2503.T
View MoreValuation Measures
Market Cap
1.71T
Enterprise Value
2.29T
Trailing P/E
15.80
Forward P/E
11.93
PEG Ratio (5yr expected)
1.44
Price/Sales (ttm)
0.75
Price/Book (mrq)
1.32
Enterprise Value/Revenue
1.00
Enterprise Value/EBITDA
7.23
Financial Highlights
Profitability and Income Statement
Profit Margin
4.73%
Return on Assets (ttm)
4.06%
Return on Equity (ttm)
10.08%
Revenue (ttm)
2.29T
Net Income Avi to Common (ttm)
108.05B
Diluted EPS (ttm)
133.44
Balance Sheet and Cash Flow
Total Cash (mrq)
154.82B
Total Debt/Equity (mrq)
59.19
Levered Free Cash Flow (ttm)
70.01B